VPHM Financial Facts
Research and development: 18.09MTotal costs and expenses: 102.36M
See Full Income Statement
Inventory: 100.12M
Total assets: 1.14B
See Full Balance Sheet
ViroPharma Inc. (VPHM) Earnings
|
Expand Research on VPHM
Next EPS Date | N/A | EPS Growth Rate | N/A |
---|---|---|---|
Average EPS % Beat Rate | +552.1% | Revenue Growth Rate | N/A |
Average % Move 1-Wk after EPS | -4.4% | Normal Earnings Time | Before Open |
Date | Qtr | EPS | Cons. | Surprise | Revs | Cons. | Gd. | 1-Week % | 1-Day % | Details | |
---|---|---|---|---|---|---|---|---|---|---|---|
10/25/12 | Q312 | -$0.07 | $0.02 | -$0.09 | $91M | $98.62M | Details | ||||
1/10/12 | Q411 | N/A | $0.41 | N/A | N/A | $143.55M | N/A | N/A | N/A | ||
8/9/12 | Q212 | $0.09 | $0.12 | -$0.03 | $94.6M | $104.27M | Details | ||||
2/27/13 | Q412 | $0.10 | $0.03 | +$0.07 | $106.5M | $103.06M | = | Details | |||
5/1/13 | Q113 | $0.15 | $0.04 | +$0.11 | $107M | $108.47M | = | Details | |||
8/1/13 | Q213 | $0.15 | $0.01 | +$0.14 | $104M | $105.06M | = | Details | |||
10/31/13 | Q313 | $0.20 | $0.05 | +$0.15 | $113M | $113.35M | = | Details | |||
5/1/12 | Q112 | $0.37 | $0.42 | -$0.05 | $135.8M | $149.16M | Details |